Currently Viewing:
Newsroom
Currently Reading
Report Finds Wide Variation in Average Cost of Healthcare Across the US
November 15, 2018 – Jaime Rosenberg
HCCI Report Shows Visits to Nurse Practitioners, Physician Assistants Soaring
November 15, 2018 – Allison Inserro
CD47 Antibody With Rituximab Produces Durable Response in R/R Lymphoma
November 15, 2018 – David Bai, PharmD
New Cholesterol Guidelines Call for Personalized Care
November 15, 2018 – Mary Caffrey
What We're Reading: Michigan Drug Pricing Experiment; ACA Enrollment; Gun Laws and Gun Deaths
November 15, 2018 – AJMC Staff
AHIP Packages Healthcare Affordability Recommendations; ACA Enrollment Dips
November 14, 2018 – Allison Inserro
Study Identifies High Burden of Invasive Infections in Neutropenic Patients
November 14, 2018 – Jaime Rosenberg
Higher BMI Decreases Risk of Breast Cancer in Premenopausal Women
November 14, 2018 – David Bai, PharmD
Provider Stigma Toward HIV Slows Prevention Goals
November 14, 2018 – Jaime Rosenberg

AJMC® in the Press, May 18, 2018

AJMC Staff
Coverage of our peer-reviewed research and news reporting in the healthcare and mainstream press.
An article in Becker’s Hospital Review highlighted an article from The American Journal of Managed Care® (AJMC®) on physician cross-checking. The AJMC® article, “Physician Cross-Checking Reduces Adverse Events in Emergency Departments,” covered a study that found systematic cross-checking between physicians in the emergency department resulted in a 40% reduction in adverse events and a 47% reduction in near misses, defined as a medical error that has the potential to cause an adverse event, but did not, either by chance or intervention.

The National Pharmaceutical Council’s Monday CER Daily Newsfeed included the AJMC® article, “Institute for Patient Access Issues Response to ICER Review of CGRP Inhibitors for Migraine.” The article reported that the Institute for Patient Access issued a response to a report by the Institute for Clinical and Economic Review stating that although CGRP inhibitors are projected to have a positive impact on the health of patients with chronic or episodic migraine, it is likely that they will exceed commonly cited willingness-to-pay thresholds.

Wednesday’s CER Daily Newsfeed included 2 articles from AJMC®. The first, “ICER Releases Draft Scoping Document on Biologics for Asthma,” reported that ICER will consider 5 monoclonal antibodies that alter the pathways involved in the type 2 inflammatory phenotype of asthma, which accounts for half of individuals with severe asthma. The second article, “Employers Play an Increasingly Important Role in the Move to Value-Based Care,” provided coverage on the keynote speech from AJMC®s Accountable Care Delivery Congress. The keynote speaker, Suzanne Delbanco, PhD, MPH, executive director of Catalyst for Payment Reform, explained that employers may not look forward to purchasing healthcare, but they, and other large purchasers, are in the position to transform the market.

WVNews, a West Virgina news outlet, highlighted an AJMC® published study in its article on opioid safety management. The study, “The Economics of Opioids: Abuse, REMS, and Treatment Benefits,” discussed the economic burden of opioid misuse; the economic impact on prescribers, payers, and patients; and the impact of the Risk Evaluation and Mitigation Strategy program.

Related Articles

The Economics of Opioids: Abuse, REMS, and Treatment Benefits
Physician Cross-Checking Reduces Adverse Events in Emergency Departments
Institute for Patient Access Issues Response to ICER Review of CGRP Inhibitors for Migraine
Employers Play an Increasingly Important Role in the Move to Value-Based Care
ICER Releases Draft Scoping Document on Biologics for Asthma
 
Copyright AJMC 2006-2018 Clinical Care Targeted Communications Group, LLC. All Rights Reserved.
x
Welcome the the new and improved AJMC.com, the premier managed market network. Tell us about yourself so that we can serve you better.
Sign Up
×

Sign In

Not a member? Sign up now!